Browse the evidence

Combining time-restricted eating (8-hour window) with concurrent aerobic and resistance training significantly improves body weight, BMI, fat mass, and functional capacity in overweight/obese women compared to control or TRE-only groups, with no significant difference between early (4pm-8am) and late (12pm-8pm) eating windows.

To lose weight and improve fitness, combine an 8-hour eating window with 3 days per week of exercise (mix of cardio and weights). You can choose to eat early (e.g., 8am-4pm) or late (e.g., 12pm-8pm); both work equally well when you exercise. Ensure you eat enough calories (1200-1500 kcal) within that window and do not snack outside it. Consistency in both diet timing and exercise is key.

Resistance training combined with high protein intake (1.6-2.0 g/kg/day) preserves or increases muscle mass during caloric restriction, whereas high protein intake alone is insufficient without resistance training.

To lose fat without losing muscle, you must lift weights (at least 10 sets per muscle group per week) and eat 1.6-2.0 grams of protein per kilogram of body weight daily. Do not rely on protein shakes or dieting alone.

Combining flexible time-restricted eating (8-hour window) with aerobic exercise yields significantly greater fat mass reduction than either intervention alone in middle-aged women with overweight/obesity.

If you are a middle-aged woman with overweight or obesity, combining an 8-hour eating window with regular moderate aerobic exercise (like brisk walking or jogging) will result in significantly more fat loss than doing either one alone. You do not need to count calories or stick to fixed meal times; simply choose an 8-hour window each day that fits your schedule and stay active.

A plant-based caloric restriction diet (PB-CRD) using a '5+2' structured meal plan is non-inferior to conventional calorie-restricted diets (CRD) for weight loss in obese adults, while providing superior reductions in total body fat percentage and improvements in metabolic markers including insulin sensitivity, uric acid, and liver enzymes.

To lose weight and improve metabolic health, you can follow a structured plant-based diet that restricts calories to 1,300-1,600 kcal/day. You do not need to be vegan 7 days a week; eating standardized plant-based meals for 5 days and allowing flexible, calorie-controlled meals for 2 days is effective. This approach matches the weight loss of traditional calorie restriction but offers better improvements in body fat percentage, insulin sensitivity, and liver health.

Daily consumption of 100 mg Kaempferia parviflora extract (SIRTMAX®) for 12 weeks significantly reduces body fat mass and visceral fat area in overweight adults compared to placebo.

Take 100 mg of Kaempferia parviflora extract (SIRTMAX®) once daily before breakfast for 12 weeks. This specific extract has been shown in a clinical trial to significantly reduce body fat mass and visceral fat in overweight adults, even without changing diet or exercise habits. It is not a magic bullet, but it provides a measurable advantage over placebo.

Adherence to the Mediterranean diet (MeDi) is associated with improved cognitive performance and a delay in cognitive decline in elderly populations, particularly when enriched with extra virgin olive oil or nuts.

Adopt a Mediterranean-style eating pattern focusing on extra virgin olive oil, vegetables, fruits, whole grains, and nuts. This approach is more effective for cognitive health than taking single supplements. Prioritize high-polyphenol olive oil and moderate wine intake if appropriate for your health profile.

Plant-based diets, particularly those emphasizing nutritious plant foods, are associated with a reduced risk of cognitive impairment and dementia compared to non-vegetarian diets.

Shift your diet to center around plants: vegetables, fruits, whole grains, legumes, nuts, and seeds. This pattern is linked to a significantly lower risk of dementia. Ensure you are eating 'nutritious' plant foods, as less healthy plant-based patterns may not offer the same benefits.

High-intensity interval training (HIIT) engages a unique subset of skeletal muscle signaling networks compared to work-matched moderate-intensity continuous training (MICT), specifically involving kinases and pathways associated with plasma lactate levels.

If you are healthy and untrained, HIIT can trigger unique muscle signaling pathways linked to metabolic health (like lactate response) that moderate continuous training does not, even when the total work done is the same. This suggests HIIT is a potent tool for metabolic adaptation.

Endoscopic Sleeve Gastroplasty (ESG) is a highly cost-effective, less invasive alternative to surgery for Class I obesity, with an ICER well below willingness-to-pay thresholds.

For Class I obesity, ESG offers a durable, cost-effective alternative to surgery with a favorable safety profile. It is particularly valuable for patients who want more than lifestyle changes but are not candidates for or willing to undergo surgery.

A poly-metabolite score derived from serum and urine metabolomics can accurately predict and discriminate between high (80% energy) and low/zero (0% energy) ultra-processed food (UPF) intake in free-living populations.

Current dietary self-reporting methods for ultra-processed foods are prone to error and misclassification. This research identifies specific blood and urine metabolite patterns that serve as objective biomarkers for UPF intake. For researchers, these scores improve the accuracy of studying UPF's health impacts. For individuals, it underscores that 'ultra-processed' is a biological reality detectable in the body, not just a label on a package, highlighting the metabolic complexity introduced by industrial food processing.

Higher consumption of sugar-sweetened beverages (SSBs) is associated with a greater increase in type 2 diabetes risk compared to artificially sweetened beverages (ASBs).

If you must choose between sugary and artificially sweetened drinks, sugary drinks pose a much higher risk for type 2 diabetes. However, both are associated with increased risk compared to not drinking them. The best choice for diabetes prevention is water or unsweetened beverages.

Obesity should be managed as a chronic, relapsing disease with long-term structured medical interventions (pharmacotherapy, surgery, behavioral therapy) rather than relying on short-term lifestyle changes, mirroring the established management model for Type 2 Diabetes Mellitus (T2DM).

Stop treating obesity as a short-term lifestyle issue. Seek a healthcare provider who recognizes it as a chronic disease. This means expecting long-term management with evidence-based tools like GLP-1 receptor agonists (e.g., semaglutide, tirzepatide), behavioral therapy, and potentially surgery, rather than just being told to 'eat less and move more.'

Metabolic bariatric surgery (MBS) procedures, specifically Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), single anastomosis duodenal-ileal bypass (SADI), and biliopancreatic diversion (BPD), provide superior long-term total body weight loss (TBWL) compared to obesity management medications (OMM) and endoscopic bariatric procedures (EBP).

If you are struggling with obesity and lifestyle changes alone have not provided sufficient long-term results, metabolic bariatric surgery (specifically RYGB, SG, SADI, or BPD) offers the highest probability of significant, sustained weight loss. While newer medications (semaglutide, tirzepatide) are excellent short-to-medium term options and comparable to surgery initially, surgery tends to maintain higher efficacy over the long term (3+ years). Consult a specialist to determine if you are a candidate for these procedures, especially if your BMI is >= 40 kg/m2.

The EMP16 combination therapy significantly improves the Fatty Liver Index (FLI) and reduces visceral adiposity index (VAI) more effectively than conventional orlistat, suggesting specific benefits for liver health beyond general weight loss.

If you have fatty liver or high visceral fat, this specific combination pill (EMP16) may offer better liver health improvements than standard orlistat. It significantly reduces the Fatty Liver Index compared to conventional treatments.

Body composition assessment (quantifying fat-free mass, fat mass, and visceral adipose tissue) provides a more accurate assessment of cardiometabolic disease risk than Body Mass Index (BMI) alone, particularly for identifying 'normal weight obesity' and sarcopenic obesity.

Stop relying solely on the scale. If you are maintaining a 'normal' BMI but feel weak or have high blood sugar, ask for a body composition assessment (like DXA or BIA). This will reveal if you have 'normal weight obesity' (high fat, low muscle) or sarcopenic obesity (high fat, low muscle), which are high-risk conditions that BMI misses. Prioritize resistance training and protein intake to build muscle, as this is the most effective way to lower metabolic risk when BMI is misleading.

Poly-metabolite scores derived from blood and urine metabolomics can objectively quantify ultra-processed food (UPF) intake, serving as a valid alternative to self-reported dietary assessments.

If you want to accurately track your ultra-processed food intake without relying on memory or self-reporting bias, emerging metabolomic scores offer a precise biological alternative. While currently a research tool, these scores objectively reflect your actual UPF consumption by analyzing specific metabolites in blood and urine, bypassing the common errors of dietary surveys.

Type 2 Diabetes Mellitus (T2DM) incidence in the United States increased nearly twenty-fold (from 3.52 to 59.30 per 1,000) between 1990 and 2024, driven by environmental and behavioral risk factors such as obesity and sedentary lifestyles.

The risk of developing Type 2 Diabetes in the US has skyrocketed over the last 30 years, largely due to lifestyle factors like obesity and inactivity, not just better testing. To mitigate this personal risk, focus on modifiable lifestyle factors (diet, activity) rather than assuming healthcare improvements have solved the underlying environmental drivers of the disease.

Native Hawaiian/Pacific Islander populations in the US face the highest diabetes burden, with incidence rates of 94.75 per 1,000 and prevalence of 20.65% in 2020-2024, significantly exceeding other racial/ethnic groups.

If you are Native Hawaiian or Pacific Islander, your statistical risk for diabetes is among the highest in the US. This is not just bad luck; it is influenced by systemic access issues. Prioritize early screening and culturally competent care that addresses both biological risks and social barriers to healthy living.

Performing leg press exercises with a knee flexion range of motion of approximately 100 degrees yields quadriceps femoris muscle hypertrophy equivalent to performing the exercise with maximum individualized knee flexion (peak ROM) in resistance-trained individuals.

If you are an experienced lifter, you do not need to force your leg press to the absolute bottom if it causes pain or technical breakdown. Stopping at approximately 100 degrees of knee flexion (where your shins are roughly perpendicular to the floor or slightly past) will build your quads just as effectively as going as deep as physically possible. Focus on reaching failure with good form at this depth rather than chasing extreme depth.

Roux-en-Y gastric bypass (RYGB) and Health Behavior Intervention (HBI) are cost-effective strategies for managing class III obesity, whereas current-price pharmacotherapies (semaglutide and tirzepatide) are not cost-effective compared to no treatment or HBI.

For individuals with class III obesity, Roux-en-Y gastric bypass offers the best long-term health outcomes and cost-effectiveness. Health Behavior Intervention (13 counseling sessions) is also cost-effective. Current GLP-1/GIP medications are not cost-effective at current prices, though lower prices could change this.

Combining CPAP with weight loss (via pharmacotherapy or lifestyle) yields greater improvements in cardiovascular risk profiles (specifically systolic blood pressure) than either treatment alone.

If you use CPAP for sleep apnea, adding weight loss (through diet, exercise, or medications like Tirzepatide) provides extra protection for your heart and blood pressure that CPAP alone does not offer. The combination is superior to either treatment by itself.

Low-load, high-volume resistance training is as effective as high-load resistance training for maximizing strength.

If your goal is to get stronger (maximal strength), you need to lift heavier loads. Lighter weights with high repetitions are not as effective for this specific goal.

When resistance training is performed to volitional fatigue, muscle hypertrophy is independent of the external load used (high vs. low), provided volume load is matched or effort is equivalent.

You do not need to lift heavy weights to build muscle. If you use lighter weights (30-40% of your max), you must perform more reps (20-25) and push until you physically cannot complete another rep with good form. This effort-to-failure approach yields the same muscle growth as heavy lifting (70-80% max) done for fewer reps (8-12). Ensure you eat enough protein (at least 1.6g per kg of body weight) and train consistently 3 times a week.

Using lean body mass (LBM) and body fat percentage (BF) in reference equations for peak oxygen uptake (VO2peak) provides better calibration for overweight and obese individuals compared to equations based on total body mass.

If you are overweight or obese, standard fitness tests that use your total body weight to predict your maximum oxygen uptake (VO2peak) likely overestimate your fitness level. To get an accurate assessment of your cardiorespiratory health, especially if you are older, use reference equations that account for your lean body mass and body fat percentage. This prevents being falsely categorized as 'fit' when your actual functional capacity may be lower.